Objective To investigate the profession development status of intra-veineuse (IV) nurse team in Anhui province, provide the reference and baseline data on intravenous therapy management of province unity standard. Methods Using the cluster sampling method, the questionnaire designed by IV professional committee of Anhui province was used to investigate the status of IV nurse team in 137 hospitals. Results IV nurse in 35 hospitals (25.6%) was accepted the intravenous treatment knowledge training, however no specific provision for training time in 91 hospitals (66.4%). Organization in PICC evaluation was diversified, such as manufacturer (40 accounted for 29.2%), nursing association in province (city)( 38 accounted for 27.7%) and nursing department in hospital (36 accounted for 26.3%). 28 hospitals had PIVAS (20.4%). 62 hospitals established IV nurse team (45.3%), 87 hospitals established IV quality control system (63.5%). Implementation strength was good in the special inspection, the following feedback in standardized operation and adverse events (81 accounted for 59.1%, 72 accounted for 52.6%and 75 accounted for 54.7%, respectively), however, there was no enough emphasis on regular meeting, organization consultation and collection data of regular basis (59 accounted for 43.1%, 52 accounted for 38.0%and 32 accounted for 23.4%, respectively). Conclusions IV nurse team has been preliminarily established in Anhui province, however there are some problems, for example, specialist nurse training and examination is not unified, overall quality control system have not established, external conditions need to be improved. Related departments should actively formulate corresponding countermeasure to promote the healthy development of the IV nurse team.

This article summarizes the origin, advantages, application status, and development trend of patient-reported outcome measurements, the common reported outcome measurements in lung cancer patients, and problems with patient-reported outcome measurements in the field of lung cancer. This article aims at exploring the application prospects of patient-reported outcome measurements in the field of lung cancer, and provide theoretical support for the formulation of medical policies and the development of lung cancer patients reported outcomes.